XML 68 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity - Schedule of Restricted Stock and Contingent Restricted Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Jun. 30, 2022
Number of Restricted Shares      
Granted (in shares) 400,000 300,000  
Unvested, end of period (in shares) 572,268    
Weighted Average Grant-Date Fair Value      
Unvested, end of period (in USD per share) $ 6.28    
Restricted Stock      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 341,211    
Vested (in shares) (118,515)    
Forfeited (in shares) (25,620)    
Unvested, end of period (in shares) 572,268   341,211
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 4.54    
Vested (in USD per share) 5.14    
Forfeited (in USD per share) 6.51    
Unvested, end of period (in USD per share) $ 6.28   $ 4.54
Unamortized compensation expense $ 3,081   $ 1,092
Weighted Average Remaining Amortization Period (Years) 2 years 6 months   2 years 1 month 6 days
Restricted Stock, Performance Based      
Number of Restricted Shares      
Granted (in shares) 91,198 100,000  
Unvested, end of period (in shares) 183,748    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 7.56    
Unvested, end of period (in USD per share) $ 5.28    
Restricted Stock Time Vested      
Number of Restricted Shares      
Granted (in shares) 283,994 100,000  
Unvested, end of period (in shares) 388,520    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 7.51    
Unvested, end of period (in USD per share) $ 6.76    
Contingent Restricted Stock Grants      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 50,062    
Forfeited (in shares) (3,787)    
Unvested, end of period (in shares) 91,877   50,062
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 2.21    
Forfeited (in USD per share) 3.69    
Unvested, end of period (in USD per share) $ 3.51   $ 2.21
Unamortized compensation expense $ 243   $ 68
Weighted Average Remaining Amortization Period (Years) 2 years 3 months 18 days   1 year 8 months 12 days
Performance Based Contingent Shares      
Number of Restricted Shares      
Granted (in shares) 45,602    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 4.95